Irritable Bowel Syndrome news from FierceBiotech
News
ALSO NOTED: Cancer-sniffing dog being cloned; Investment spurs Bioton shares; Genetic Chemistry wins $23M contract; Tioga touts
> The world's top cancer-sniffing canine has been cloned, and her owners are planning a pack of clones to join the hunt for canine cancer detection. Researchers have been testing dogs' ability to Read more...
ALSO NOTED: Endo buys Novartis' Voltaren; Microbia, Forest produce positive Phase III data; and much more...
> Endo Pharmaceutical is buying Novartis' Voltaren gel for $85 million upfront and a one-time sales milestone of $25 million. Read more...
Ocera gins $35.5M in third venture round
San Diego-based Ocera Therapeutics has lined up $35.5 million in its third venture round to push the further development of its lead--and only--therapy: AST-120, which was in-licensed from Japan's Read more...
ALSO NOTED: Dynogen goes public; Alpharma sells ingredients unit for $395M; Arizona launches new venture fund; and much more...
> Dynogen Pharmaceuticals is going public in a buyout deal with Apex Bioventures Acquisition Corp. Dynogen shareholders will initially receive $98 million in the deal, with Dynogen merging with a Read more...
Microbia, Forest ink $330M deal
Microbia is pocketing a $70 million up front payment from Forest Laboratories in exchange for a 50/50 U.S. development pact for linaclotide, an experimental therapy for irritable bowel syndrome and Read more...
Salix shares rise on new data, deals
Shares of Raleigh, NC-based Salix Pharmaceuticals surged about 20 percent this morning after the company announced a trifecta of upbeat developments. New trial data are supporting two of its Read more...
SPOTLIGHT: FDA allows limited Zelnorm use
The FDA said it will allow the restricted use of Zelnorm under an IND protocol to treat irritable bowel syndrome with constipation and chronic idiopathic constipation in women younger than 55 who Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets